Prostate Cancer

Prostate Cancer
Study: Prostate Cancer Imaging Scans Often Unnecessary
Thousands of men with low-risk prostate cancer are undergoing unnecessary and expensive imaging tests, while thousands of men with high-risk disease who should get the tests are not.
Can Pomegranate Pills Fight Prostate Cancer?
Taking a pomegranate pill a day may help slow the progression of prostate cancer, preliminary research suggests.
Is Early Balding Linked to Prostate Cancer?
Men who start to go bald by age 20 may have an increased risk for developing prostate cancer later in life, a study suggests.
Gene Test for Prostate Cancer in the Works
Researchers are a step closer to developing a genetic test that could help men with newly diagnosed prostate cancer decide whether they are good candidates for active surveillance or whether they need treatment right away.
New Insight on Weight Gain After Prostate Cancer Therapy
A new study shows that the weight gain associated with a form of hormone therapy called androgen-deprivation therapy (ADT) appears to level off after the first year of treatment.
New Doubts on Value of Prostate Cancer Screening
A study from Sweden raises new questions about the value of screening average-risk men for prostate cancer.
FDA Approves Prostate Cancer Drug Zytiga
The FDA has approved the Johnson & Johnson pill Zytiga for use in combination with the steroid prednisone to treat a certain type of late-stage prostate cancer in men who have already been treated with chemotherapy.
Prostate Cancer: Early Surgery or Watchful Waiting?
Fifteen-year results from a Swedish study find that early prostate surgery cuts deaths in under-65 men with "low-risk" prostate tumors -- but men at low-risk by today's standards may do better if they wait.
New Debate on PSA Test for Prostate Cancer
Men with a PSA (prostate-specific antigen) level of less than 1 nanogram per liter of blood can safely wait up to eight years between PSA screenings, researchers say.
Coffee May Lower Prostate Cancer Risk
Men who drink coffee regularly appear to lower their risk of prostate cancer, especially the lethal form, new research suggests.
Predicting Sexual Ability After Prostate Cancer Treatment
The better a man's erections before prostate cancer treatment, the more likely he is to recover the ability to have erections later.
Obesity May Raise Risk of Prostate Cancer Spread
Obesity and prostate cancer may be a bad combination, new research suggests. The risk of the cancer spreading is more likely in both obese and overweight men, researchers found.
Combination Therapy May Treat Prostate Cancer
For some men with early-stage prostate cancer, adding short-term hormone treatment to radiation therapy improves their chances of survival, according to a new study.
Brisk Walking May Help Keep Prostate Cancer in Check
Brisk walking may help men diagnosed with early-stage prostate cancer reduce their risk of progression of the disease, according to a new study.
Prostate Cancer Drug Zytiga May Extend Life
The newly approved prostate cancer pill Zytiga (abiraterone acetate) may extend life by up to four months among men with spreading cancer who have already been treated with chemotherapy, a study shows.
5 Genes Linked to Aggressive Prostate Cancer
Researchers in Seattle and Sweden have identified five inherited genetic markers that could help spot men with the most aggressive and deadly forms of prostate cancer.
Urine Test May Help Predict Prostate Cancer
A painless urine test could soon help doctors tell when a high prostate specific antigen (PSA) level means a dangerous cancer or when it’s a sign of a more benign condition that may not need further treatment, a new study shows.
Infections Linked to Biopsies for Prostate Cancer
New research raises concerns about a rise in potentially serious infections that require hospitalization in men who have prostate biopsies.
Shorter Course of Radiation May Treat Prostate Cancer
A shorter, cheaper, and more convenient five-week course of radiation appears to work just as well as the traditional seven-and-one-half week schedule for men with prostate cancer, a study shows.
Task Force to Men: Don't Get PSA Test
Men should just say "no" to prostate cancer screening with the common PSA blood test, according to draft guidelines from the U.S. Preventive Services Task Force.
Common Prostate Cancer Treatment May Be Less Risky Than Thought
Just over a year ago the FDA warned that commonly used hormone-blocking treatments may increase the risk for fatal heart attacks in prostate cancer patients, but a new analysis finds these fears to be unfounded for most men.
Drug for Enlarged Prostate May Slow Cancer Growth
Avodart, a drug widely used in the treatment of enlarged prostates, may slow cancer growth in men with very early prostate cancers.
Study: Radioactive Seeds Beat Out Other Prostate Cancer Treatments
For most men with prostate cancer, having radioactive seeds implanted in the prostate is associated with fewer serious side effects than either surgery to remove the prostate or having a beam of high-energy radiation aimed directly at the cancer, researchers say.
Strategy for Incontinence From Prostate Cancer Surgery
Pelvic-floor-muscle exercises along with other bladder control strategies, such as keeping a diary and monitoring your daily fluid intake, can help halve weekly incontinence episodes among men with prostate cancer who underwent surgery to remove their prostate gland (radical prostatectomy), a study shows.
Exercise Cuts Prostate Cancer Death Risk
Men diagnosed with prostate cancer may be able to reduce their risk of death not just from prostate cancer but from any cause by exercising vigorously for at least three hours per week, new research indicates.

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.